Mohamed Abdelrahman Alhefnawy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mohamed Abdelrahman Alhefnawy has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Wahsh
Department of Urology, Faculty of Medicine, Al-Azhar University, Assiut.
2 shared publications - Alaa Rafaat Mahmoud
Urology Department, Al-Azhar University, Asyut, Egypt
2 shared publications - Hazem Deif
Urology Department, Al-Azhar University, Asyut, Egypt
2 shared publications - Helmy Ahmed Eldib
Urology Department, Benha University, Benha, Egypt
2 shared publications - Khaled Almekaty
Urology Department, Tanta University, Tanta, Egypt
2 shared publications - Mohamed Aboulfotouh El Gharably
Department of Urology, Cairo University Kasralainy School of Medicine, Cairo, Egypt ; Department of Urology, Southend University Hospital, Mid and South Essex NHS Foundation Trust, Essex, UK
2 shared publications
Latest Publications
- Open Access
- 14 May 2026
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 52, 1-9
Efficacy and Safety of Mirabegron 25 mg Versus Oral Desmopressin 120 mcg in Treatment of Primary Nocturnal Enuresis
Objective: To evaluate the effectiveness and safety of mirabegron in the management of primary nocturnal enuresis. Methods: This prospective, randomized controlled study included 150 patients randomized into 2 equal groups: desmopressin and mirabegron. All patients underwent evaluation over a 6-month period, with assessments conducted at the end of each month. Evaluations included the frequency of wet nights per month, clinical outcomes, the percentage reduction in wet nights during treatment, and relapse following treatment. The side effects of the drugs in the studied groups were also recorded. Results: At 2, 3, 4, 5, and 6 months, the mirabegron group showed a significant increase in median percentage reduction in wet nights from baseline compared with the desmopressin group. Furthermore, there was a significant improvement in clinical outcomes for the mirabegron group compared to the desmopressin group (P < .01*). At the 1-month follow-up after treatment, 10.7% of patients in the mirabegron group had a relapse, whereas the relapse rate in the desmopressin group was 22.7%, indicating a statistically significant difference (P = .049*); the relative risk of relapse with mirabegron was 0.47 (95% CI: 0.22-1.02). The mirabegron group exhibited a significant increase in maximum bladder capacity (MBC) (270.8 ± 73.80) compared to the desmopressin group (230.933 ± 67.35; P < .001). Both groups exhibited a statistically significant increase in MBC posttreatment compared with pretreatment (P < .001*). No significant difference was observed between the 2 groups regarding any of the reported side effects. Conclusion: Mirabegron is an effective treatment for nocturnal enuresis, with better outcomes, fewer relapses, and tolerable side effects. Cite this article as: Abo-Elnasr HA, Alhefnawy MA, Farag M, El Gharably MA. Efficacy and safety of mirabegron 25 mg versus oral desmopressin 120 mcg in treatment of primary nocturnal enuresis. Urol Res Pract. 2026, 52, 0009, doi: 10.5152/ tud.2026.26009.
- 14 May 2026
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 52, 1-9
Open AccessEfficacy and Safety of Mirabegron 25 mg Versus Oral Desmopressin 120 mcg in Treatment of Primary Nocturnal Enuresis
Objective: To evaluate the effectiveness and safety of mirabegron in the management of primary nocturnal enuresis. Methods: This prospective, randomized controlled study included 150 patients randomized into 2 equal groups: desmopressin and mirabegron. All patients underwent evaluation over a 6-month period, with assessments conducted at the end of each month. Evaluations included the frequency of wet nights per month, clinical outcomes, the percentage reduction in wet nights during treatment, and relapse following treatment. The side effects of the drugs in the studied groups were also recorded. Results: At 2, 3, 4, 5, and 6 months, the mirabegron group showed a significant increase in median percentage reduction in wet nights from baseline compared with the desmopressin group. Furthermore, there was a significant improvement in clinical outcomes for the mirabegron group compared to the desmopressin group (P < .01*). At the 1-month follow-up after treatment, 10.7% of patients in the mirabegron group had a relapse, whereas the relapse rate in the desmopressin group was 22.7%, indicating a statistically significant difference (P = .049*); the relative risk of relapse with mirabegron was 0.47 (95% CI: 0.22-1.02). The mirabegron group exhibited a significant increase in maximum bladder capacity (MBC) (270.8 ± 73.80) compared to the desmopressin group (230.933 ± 67.35; P < .001). Both groups exhibited a statistically significant increase in MBC posttreatment compared with pretreatment (P < .001*). No significant difference was observed between the 2 groups regarding any of the reported side effects. Conclusion: Mirabegron is an effective treatment for nocturnal enuresis, with better outcomes, fewer relapses, and tolerable side effects. Cite this article as: Abo-Elnasr HA, Alhefnawy MA, Farag M, El Gharably MA. Efficacy and safety of mirabegron 25 mg versus oral desmopressin 120 mcg in treatment of primary nocturnal enuresis. Urol Res Pract. 2026, 52, 0009, doi: 10.5152/ tud.2026.26009.
- 21 April 2026
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1)
Comparative evaluation of flexible and navigable suction sheath (FANS), percutaneous nephrostomy (PCN), and conventional ureteral access sheath (UAS) during retrograde intrarenal surgery: a randomized controlled trial
Optimizing drainage during retrograde intrarenal surgery (RIRS) is crucial for procedural efficacy and safety. Flexible and navigable suction ureteral access sheath (FANS) offers active intrarenal suction without external access, while percutaneous nephrostomy (PCN) provides reliable but invasive drainage. This study compared the efficacy and safety of FANS versus PCN tube drainage during RIRS as compared to conventional ureteral access sheath (UAS). This randomized controlled trial included 217 adult patients with renal stones (14-27 mm) undergoing RIRS. Patients were randomized into three groups: (UAS, n = 72), PCN (n = 72), and FANS (n = 73). Outcomes assessed included operative time, stone-free rate (SFR), complications, and postoperative recovery. SFR was significantly higher with PCN (97.2%) and FANS (98.6%) versus UAS (81.9%; p < 0.001). The mean operative time was shorter with PCN (48 ± 14 min) than UAS (58 ± 13 min) and FANS (58 ± 11 min; p < 0.001). Loin/suprapubic pain and hematuria were more frequent with UAS, whereas infectious and major complications were infrequent and similar. On stepwise multivariable analysis, lower Hounsfield units and use of PCN (OR 7.756, 95% CI 1.655-36.346) or FANS (OR 17.25, 95% CI 2.156-138.024) independently predicted stone-free status. PCN and FANS are both effective and safe drainage strategies during RIRS and outperform conventional UAS in SFR. FANS provides a minimally invasive, entirely endoscopic alternative to PCN with comparable safety and efficacy.
- 21 April 2026
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1)
Comparative evaluation of flexible and navigable suction sheath (FANS), percutaneous nephrostomy (PCN), and conventional ureteral access sheath (UAS) during retrograde intrarenal surgery: a randomized controlled trial
Optimizing drainage during retrograde intrarenal surgery (RIRS) is crucial for procedural efficacy and safety. Flexible and navigable suction ureteral access sheath (FANS) offers active intrarenal suction without external access, while percutaneous nephrostomy (PCN) provides reliable but invasive drainage. This study compared the efficacy and safety of FANS versus PCN tube drainage during RIRS as compared to conventional ureteral access sheath (UAS). This randomized controlled trial included 217 adult patients with renal stones (14-27 mm) undergoing RIRS. Patients were randomized into three groups: (UAS, n = 72), PCN (n = 72), and FANS (n = 73). Outcomes assessed included operative time, stone-free rate (SFR), complications, and postoperative recovery. SFR was significantly higher with PCN (97.2%) and FANS (98.6%) versus UAS (81.9%; p < 0.001). The mean operative time was shorter with PCN (48 ± 14 min) than UAS (58 ± 13 min) and FANS (58 ± 11 min; p < 0.001). Loin/suprapubic pain and hematuria were more frequent with UAS, whereas infectious and major complications were infrequent and similar. On stepwise multivariable analysis, lower Hounsfield units and use of PCN (OR 7.756, 95% CI 1.655-36.346) or FANS (OR 17.25, 95% CI 2.156-138.024) independently predicted stone-free status. PCN and FANS are both effective and safe drainage strategies during RIRS and outperform conventional UAS in SFR. FANS provides a minimally invasive, entirely endoscopic alternative to PCN with comparable safety and efficacy.
- Open Access
- 24 December 2025
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 97 (4) , 14330
Evaluation of carcinogenicity following intratesticular transplantation of autologous bone marrow-derived mesenchymal stem cells in non-obstructive azoospermia patients: a retrospective analysis
Background: Non-obstructive azoospermia (NOA) cases may have severely deficient spermatogenesis and inadequate sperm production. Despite increasing clinical investigations emphasizing the safety of mesenchymal stem cell (MSC) therapy in NOA cases, no article has recently reviewed the adverse events and carcinogenicity after transplantation. Objective: the study was conducted to evaluate the safety and potential carcinogenic effects of autologous human bone marrow- MSCs implanted into the testes of patients with NOA. Methods: This retrospective cohort study was conducted throughout the period from January2017 to January 2022, encompassed 100 patients aged 20-40 years with primary infertility, with NOA for at least 2 years duration who had a confirmed diagnosis of NOA, based on two separate semen analyses showing azoospermia with centrifugation, conducted at least three months apart. Patients were submitted to intratesticular transplantation of autologous bone marrow-derived mesenchymal stem cells. Records of all participants were examined to acquire the demographic data of patients, laboratory investigations including β-HCG, ECG, AFP, LDH, and scrotal ultrasound examination. Results: there is no significant malignancy or cancer occurrence post- MSCs therapy as indicated by the normal level of the tumor marker levels for LDH (183.4 ± 31.5) u/L, AFP (3.16 ± 1.6) ng/ ml, CEA (2.27 ± 1.1) ng/ ml, and β-HCG (0.95 ± 0.2) mIU/mL. Additionally, scrotal ultrasound showed no focal findings in all cases. Conclusions: there is no carcinogenic effect of mesenchymal stem cells implanted into testes.
- 24 December 2025
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 97 (4) , 14330
Open AccessEvaluation of carcinogenicity following intratesticular transplantation of autologous bone marrow-derived mesenchymal stem cells in non-obstructive azoospermia patients: a retrospective analysis
Background: Non-obstructive azoospermia (NOA) cases may have severely deficient spermatogenesis and inadequate sperm production. Despite increasing clinical investigations emphasizing the safety of mesenchymal stem cell (MSC) therapy in NOA cases, no article has recently reviewed the adverse events and carcinogenicity after transplantation. Objective: the study was conducted to evaluate the safety and potential carcinogenic effects of autologous human bone marrow- MSCs implanted into the testes of patients with NOA. Methods: This retrospective cohort study was conducted throughout the period from January2017 to January 2022, encompassed 100 patients aged 20-40 years with primary infertility, with NOA for at least 2 years duration who had a confirmed diagnosis of NOA, based on two separate semen analyses showing azoospermia with centrifugation, conducted at least three months apart. Patients were submitted to intratesticular transplantation of autologous bone marrow-derived mesenchymal stem cells. Records of all participants were examined to acquire the demographic data of patients, laboratory investigations including β-HCG, ECG, AFP, LDH, and scrotal ultrasound examination. Results: there is no significant malignancy or cancer occurrence post- MSCs therapy as indicated by the normal level of the tumor marker levels for LDH (183.4 ± 31.5) u/L, AFP (3.16 ± 1.6) ng/ ml, CEA (2.27 ± 1.1) ng/ ml, and β-HCG (0.95 ± 0.2) mIU/mL. Additionally, scrotal ultrasound showed no focal findings in all cases. Conclusions: there is no carcinogenic effect of mesenchymal stem cells implanted into testes.
- Open Access
- 24 February 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-12
Cavernous tissue preservation technique versus conventional technique during penile prosthesis implantation: a prospective comparative study
Background: Few prospective studies in literature with long postoperative follow-up compared between cavernous tissue sparing and conventional penile prosthesis implantation techniques. Aim: To compare between cavernous tissue sparing and conventional penile prosthesis implantation techniques in terms of patient and partner satisfaction and perioperative outcomes. Methods: In All, 60 Patients with severe erectile dysfunction were randomized into 2 equal groups; patients undergoing conventional malleable penile prosthesis implantation, and patients undergoing the cavernous tissue-sparing technique. Postoperatively, prosthesis function and patient satisfaction were assessed at 6 weeks after surgery and then 3–6 and 12 months using EDITS and QoLSPP questionnaires. Patients were asked about residual penile tumescence. Perioperative data were recorded. Results: Modified EDITS questionnaire after 3,6, and 12 months was 76.9 ± 18, 79 ± 17 and 82.3 ± 16 respectively. As QOLSPP questionnaire, 46 (73.8%) subjects were highly satisfied, 25 patients (83.3%) in cavernous tissue sparing and 21 patients (70.00%) in Conventional group. While 14 (26.2%) were less satisfied, 5 patients (16.7%) Cavernous tissue sparing and 9 patients (30.00%) in Conventional group. In the cavernous tissue-sparing group, 26 of 30 patients (86.6%) reported having a significantly higher incidence of residual penile tumescence versus 2 of 30 patients (6.6%) in the conventional surgery group (P < .001). The age of highly satisfied subjects was significantly lower than those less satisfied (p = 0.025), while the BMI of highly satisfied subjects was significantly lower than those less satisfied (p = 0.001). Conclusion: There is a significantly higher incidence of residual penile tumescence in Cavernous tissue sparing group. Many factors affect male satisfaction rates after PPI as age, and BMI.
- 24 February 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-12
Open AccessCavernous tissue preservation technique versus conventional technique during penile prosthesis implantation: a prospective comparative study
Background: Few prospective studies in literature with long postoperative follow-up compared between cavernous tissue sparing and conventional penile prosthesis implantation techniques. Aim: To compare between cavernous tissue sparing and conventional penile prosthesis implantation techniques in terms of patient and partner satisfaction and perioperative outcomes. Methods: In All, 60 Patients with severe erectile dysfunction were randomized into 2 equal groups; patients undergoing conventional malleable penile prosthesis implantation, and patients undergoing the cavernous tissue-sparing technique. Postoperatively, prosthesis function and patient satisfaction were assessed at 6 weeks after surgery and then 3–6 and 12 months using EDITS and QoLSPP questionnaires. Patients were asked about residual penile tumescence. Perioperative data were recorded. Results: Modified EDITS questionnaire after 3,6, and 12 months was 76.9 ± 18, 79 ± 17 and 82.3 ± 16 respectively. As QOLSPP questionnaire, 46 (73.8%) subjects were highly satisfied, 25 patients (83.3%) in cavernous tissue sparing and 21 patients (70.00%) in Conventional group. While 14 (26.2%) were less satisfied, 5 patients (16.7%) Cavernous tissue sparing and 9 patients (30.00%) in Conventional group. In the cavernous tissue-sparing group, 26 of 30 patients (86.6%) reported having a significantly higher incidence of residual penile tumescence versus 2 of 30 patients (6.6%) in the conventional surgery group (P < .001). The age of highly satisfied subjects was significantly lower than those less satisfied (p = 0.025), while the BMI of highly satisfied subjects was significantly lower than those less satisfied (p = 0.001). Conclusion: There is a significantly higher incidence of residual penile tumescence in Cavernous tissue sparing group. Many factors affect male satisfaction rates after PPI as age, and BMI.
- Open Access
- 3 January 2025
- Published by Springer Nature in Urolithiasis
- Vol. 53 (1) , 1-9
Ureteral access sheath or percutaneous nephrostomy during flexible ureteroscopy: which is better?
Studies in literature discussed the drawbacks of the ureteral access sheath use in flexible ureteroscopy and in the same time mentioned the benefits of ureteral access sheath in decreasing the incidence of urosepsis and better stone free rate. In the current study we aim to compare between percutaneous nephrostomy tube (PCN) insertion before flexible ureteroscopy and conventional ureteral access sheath (UAS) flexible ureteroscopy in terms of safety, efficacy and perioperative outcomes. In all, 100 Patients aged 20 to 67 years with upper ureteric stones and mild hydronephrosis or renal pelvic stones less than 20 mm with mild hydronephrosis were randomized into 2 groups; patients undergoing PCN insertion before flexible ureteroscopy, and patients undergoing the conventional UAS flexible ureteroscopy. Patients with active urinary tract infection, patients with urinary diversions or malformations and patients with uncontrolled coagulable status were excluded from the study. Perioperative data were recorded. This study was conducted on 50 PCN group and 50 UAS group. Age varied from 20.0 to 67.0 years. Males consisted more than half of study groups, 52% of PCN group and 66% of UAS group. Weak significant difference was found in need for ureteral pre-operative stenting between groups (8% with PCN vs. 22% with UAS, p 0.04995). There was no significant difference between two groups in intra-operative complications (mucosal injury, failed operation, perforation, false passage and conversion to other procedure), but there was significant difference in bleeding between the groups (6% with PCN vs. 22% with UAS, p = 0.021). There was no significant difference between two groups in post-operative complications (infection, fever, pain, hematuria, other complications, stone free rate, readmission and stent duration), but there was significant decrease in operative time (48.85 ± 13.861 in PCN group versus 56.82 ± 14.61 in UAS group, p = 0.0003). We conclude that PCN insertion before flexible ureteroscopy provides a safe technique with comparable outcomes to UAS use.
- 3 January 2025
- Published by Springer Nature in Urolithiasis
- Vol. 53 (1) , 1-9
Open AccessUreteral access sheath or percutaneous nephrostomy during flexible ureteroscopy: which is better?
Studies in literature discussed the drawbacks of the ureteral access sheath use in flexible ureteroscopy and in the same time mentioned the benefits of ureteral access sheath in decreasing the incidence of urosepsis and better stone free rate. In the current study we aim to compare between percutaneous nephrostomy tube (PCN) insertion before flexible ureteroscopy and conventional ureteral access sheath (UAS) flexible ureteroscopy in terms of safety, efficacy and perioperative outcomes. In all, 100 Patients aged 20 to 67 years with upper ureteric stones and mild hydronephrosis or renal pelvic stones less than 20 mm with mild hydronephrosis were randomized into 2 groups; patients undergoing PCN insertion before flexible ureteroscopy, and patients undergoing the conventional UAS flexible ureteroscopy. Patients with active urinary tract infection, patients with urinary diversions or malformations and patients with uncontrolled coagulable status were excluded from the study. Perioperative data were recorded. This study was conducted on 50 PCN group and 50 UAS group. Age varied from 20.0 to 67.0 years. Males consisted more than half of study groups, 52% of PCN group and 66% of UAS group. Weak significant difference was found in need for ureteral pre-operative stenting between groups (8% with PCN vs. 22% with UAS, p 0.04995). There was no significant difference between two groups in intra-operative complications (mucosal injury, failed operation, perforation, false passage and conversion to other procedure), but there was significant difference in bleeding between the groups (6% with PCN vs. 22% with UAS, p = 0.021). There was no significant difference between two groups in post-operative complications (infection, fever, pain, hematuria, other complications, stone free rate, readmission and stent duration), but there was significant decrease in operative time (48.85 ± 13.861 in PCN group versus 56.82 ± 14.61 in UAS group, p = 0.0003). We conclude that PCN insertion before flexible ureteroscopy provides a safe technique with comparable outcomes to UAS use.
- Open Access
- 2 October 2024
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 96 (3) , 12595
Effect of radiofrequency electromagnetic waves of mobile phone stations on male fertility
Purpose: To determine the effect of electromagnetic waves of mobile phone stations on several sperm parameters and the male reproductive system. Methods: This observational study was performed on 216 subjects, aged 18-60 years. Two equal groups of subjects were assigned to group A (study group) if they were living close to cell phone tower stations for at least 6 months and group B (control group) formed from individuals living 100 meters away from cell phone tower stations. Every subject underwent a comprehensive history taking, a clinical assessment, and laboratory testing. Results: Regarding morphology index in the studied groups, the exposed group exhibited a trend of reduced percentage of normal morphology compared to the non-exposed group, with no statistical difference between the two groups. Regarding the total sperm motility (A+B+C) and progressive sperm motility (A+B) in the studied groups, the exposed group showed a trend of decreased total sperm motility and of progressive sperm motility in contrast to the non-exposed group, with no statistical difference between the two groups. Conclusions: Personal wrong lifestyles with exposure to electromagnetic waves have shown a trend towards a reduced percentage of normal morphology and reduced motility although nonstatistically significant compared with non-exposed populations.
- 2 October 2024
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 96 (3) , 12595
Open AccessEffect of radiofrequency electromagnetic waves of mobile phone stations on male fertility
Purpose: To determine the effect of electromagnetic waves of mobile phone stations on several sperm parameters and the male reproductive system. Methods: This observational study was performed on 216 subjects, aged 18-60 years. Two equal groups of subjects were assigned to group A (study group) if they were living close to cell phone tower stations for at least 6 months and group B (control group) formed from individuals living 100 meters away from cell phone tower stations. Every subject underwent a comprehensive history taking, a clinical assessment, and laboratory testing. Results: Regarding morphology index in the studied groups, the exposed group exhibited a trend of reduced percentage of normal morphology compared to the non-exposed group, with no statistical difference between the two groups. Regarding the total sperm motility (A+B+C) and progressive sperm motility (A+B) in the studied groups, the exposed group showed a trend of decreased total sperm motility and of progressive sperm motility in contrast to the non-exposed group, with no statistical difference between the two groups. Conclusions: Personal wrong lifestyles with exposure to electromagnetic waves have shown a trend towards a reduced percentage of normal morphology and reduced motility although nonstatistically significant compared with non-exposed populations.
- Open Access
- 7 March 2024
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 96 (1) , 12285
Evaluation of human bone marrow mesenchymal stem cells in the treatment of non obstructive azoospermia
Background: Non-obstructive azoospermia (NOA) represents an infertility problem that is usually difficult to treat. Such patients usually have testicular biopsy of germ cell aplasia or spermatogenic arrest. In recent decades, mesenchymal stem cells (MSCs) had been studied thoroughly and proved safe and effective regarding their capability for trans-differentiation into different cell types. The aim of this study was to evaluate the effect of MSCs local intratesticular injection in induction of spermatogenesis. Patients and method: The current study included 87 infertile non-obstructive azoospermic patients. Clinical assessment and repeated semen analysis with centrifugation were done to confirm azoospermia. Karyotyping and AZF study were done. Some of the patients had previous testicular biopsy proving a lack of sperm in the testes. Single intratesticular injection of purified MSCs suspension was done. Results: 20.7% of patients showed sperm in their semen after variable period of time. Hormonal profile among treated patients showed significant improvement regardless success of treatment. Also most of the treated patients appreciated the improvement of their sexual function and libido. Conclusions: Bone marrow derived MSCs could be a new hope and therapeutic modality for treatment of refractory cases of NOA.
- 7 March 2024
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 96 (1) , 12285
Open AccessEvaluation of human bone marrow mesenchymal stem cells in the treatment of non obstructive azoospermia
Background: Non-obstructive azoospermia (NOA) represents an infertility problem that is usually difficult to treat. Such patients usually have testicular biopsy of germ cell aplasia or spermatogenic arrest. In recent decades, mesenchymal stem cells (MSCs) had been studied thoroughly and proved safe and effective regarding their capability for trans-differentiation into different cell types. The aim of this study was to evaluate the effect of MSCs local intratesticular injection in induction of spermatogenesis. Patients and method: The current study included 87 infertile non-obstructive azoospermic patients. Clinical assessment and repeated semen analysis with centrifugation were done to confirm azoospermia. Karyotyping and AZF study were done. Some of the patients had previous testicular biopsy proving a lack of sperm in the testes. Single intratesticular injection of purified MSCs suspension was done. Results: 20.7% of patients showed sperm in their semen after variable period of time. Hormonal profile among treated patients showed significant improvement regardless success of treatment. Also most of the treated patients appreciated the improvement of their sexual function and libido. Conclusions: Bone marrow derived MSCs could be a new hope and therapeutic modality for treatment of refractory cases of NOA.
- Open Access
- 21 November 2023
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 95 (4)
Autologous mesenchymal stem cell therapy for diabetic men with erectile dysfunction. Is it promising? A pilot study
Purpose: to assess safety and efficacy of autologous mesenchymal bone marrow stem cell injection in penile cavernosal tissue for erectile dysfunction therapy in diabetic men. Methods: The subjects of this study were diabetic men suffering erectile dysfunction, non-responding to maximum dose of oral PDE5I. Mesenchymal bone marrow stem cells were aspirated and injected after preparation in both corpora cavernosa at 3, 9 o’clock position. Erectile function was assessed by the International Index of Erectile Function and penile Doppler study, before and after 6 months after injection. Results: 4 patients out of 10 achieve hard erection adequate for satisfactory coitus, and 2 patients achieved penile hardness with addition of pharmacological therapy with sildenafil 100mg. Peak systolic velocity increased significantly in 4 patients (2 arteriogenic and 2 mixed erectile dysfunction), from 12∼22 cm/s to 32∼69 cm/s. Variations in end-diastolic velocity increased substantially in 2 patients with venogenic insufficiency alone at follow-up from 4∼5 cm /s to -4∼-3 cm/s. Conclusions: Despite promising stem cell treatment efficacy for patients with erectile dysfunction, more clinical studies and researches are still warranted.
- 21 November 2023
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 95 (4)
Open AccessAutologous mesenchymal stem cell therapy for diabetic men with erectile dysfunction. Is it promising? A pilot study
Purpose: to assess safety and efficacy of autologous mesenchymal bone marrow stem cell injection in penile cavernosal tissue for erectile dysfunction therapy in diabetic men. Methods: The subjects of this study were diabetic men suffering erectile dysfunction, non-responding to maximum dose of oral PDE5I. Mesenchymal bone marrow stem cells were aspirated and injected after preparation in both corpora cavernosa at 3, 9 o’clock position. Erectile function was assessed by the International Index of Erectile Function and penile Doppler study, before and after 6 months after injection. Results: 4 patients out of 10 achieve hard erection adequate for satisfactory coitus, and 2 patients achieved penile hardness with addition of pharmacological therapy with sildenafil 100mg. Peak systolic velocity increased significantly in 4 patients (2 arteriogenic and 2 mixed erectile dysfunction), from 12∼22 cm/s to 32∼69 cm/s. Variations in end-diastolic velocity increased substantially in 2 patients with venogenic insufficiency alone at follow-up from 4∼5 cm /s to -4∼-3 cm/s. Conclusions: Despite promising stem cell treatment efficacy for patients with erectile dysfunction, more clinical studies and researches are still warranted.
- Open Access
- 5 September 2023
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 95 (3) , 11524
The outcomes of flexible ureteroscopy for renal calculi of 2 cm or more with and without the use of ureteral access sheath: A retrospective study
Introduction: The rate of success of retrograde intrarenal surgery (RIRS) for treating urinary tract stones is high, and the procedure is growing in popularity. The routine use of ureteral access sheath (UAS) remains somewhat controversial. The aim of this study was to assess the efficacy and safety of employing UAS during flexible ureteroscopy for treating renal stones ≥ 2 cm. Methods: This retrospective study was accomplished from January 2021 to February 2023. From 495 consecutives flexible ureteroscopies, 112 patients had renal stones ≥ 2 cm (60 patients with the use of UAS and 52 patients without). The stone-free status was verified after 8 weeks of operation. Results: The average diameter of the renal stones in non-UAS or UAS treated groups was 22.5 mm and 22.6, respectively. None of the groups differed significantly in terms of stone side, stone size, stone position, or Hounsfield unite but there was significant difference (p < 0.001) among two groups as regard pre-operative stenting (cases with UAS had 23.3% pre-operative stenting). Conclusions: It is not always necessary to use UAS in conjunction with flexible ureteroscopy and laser lithotripsy to treat renal calculi bigger than or equal two cm. Without the assistance of UAS, the surgery may be carried out successfully and safely.
- 5 September 2023
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 95 (3) , 11524
Open AccessThe outcomes of flexible ureteroscopy for renal calculi of 2 cm or more with and without the use of ureteral access sheath: A retrospective study
Introduction: The rate of success of retrograde intrarenal surgery (RIRS) for treating urinary tract stones is high, and the procedure is growing in popularity. The routine use of ureteral access sheath (UAS) remains somewhat controversial. The aim of this study was to assess the efficacy and safety of employing UAS during flexible ureteroscopy for treating renal stones ≥ 2 cm. Methods: This retrospective study was accomplished from January 2021 to February 2023. From 495 consecutives flexible ureteroscopies, 112 patients had renal stones ≥ 2 cm (60 patients with the use of UAS and 52 patients without). The stone-free status was verified after 8 weeks of operation. Results: The average diameter of the renal stones in non-UAS or UAS treated groups was 22.5 mm and 22.6, respectively. None of the groups differed significantly in terms of stone side, stone size, stone position, or Hounsfield unite but there was significant difference (p < 0.001) among two groups as regard pre-operative stenting (cases with UAS had 23.3% pre-operative stenting). Conclusions: It is not always necessary to use UAS in conjunction with flexible ureteroscopy and laser lithotripsy to treat renal calculi bigger than or equal two cm. Without the assistance of UAS, the surgery may be carried out successfully and safely.